Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 961 | 966 | 875 | 730 | 734 | 767 | 741 | 871 | 1,293 | 1,674 | | 1,530 |
% Growth | NA | 0.5% | -9.4% | -16.5% | 0.6% | 4.4% | -3.3% | 17.5% | 48.5% | 29.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | (710) | (722) | (609) | (482) | (494) | (528) | (491) | (612) | (1,093) | (1,435) | | (1,177) |
Gross Profit | 252 | 244 | 265 | 249 | 240 | 238 | 250 | 258 | 200 | 239 | | 352 |
% Revenue | 26.2% | 25.3% | 30.3% | 34.1% | 32.7% | 31.1% | 33.7% | 29.7% | 15.4% | 14.3% | | 23.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (128) | (128) | (131) | (122) | (122) | (107) | (110) | (114) | (118) | (139) | | (142) |
Other Inc / (Exp) | (25) | (29) | (23) | (28) | (34) | (47) | (74) | (61) | (9) | 15 | | (28) |
Total Operating Exp | (153) | (157) | (154) | (150) | (155) | (155) | (184) | (175) | (128) | (124) | | (170) |
| | | | | | | | | | | | |
Operating Income | 98 | 87 | 111 | 98 | 85 | 84 | 66 | 83 | 72 | 116 | | 182 |
% Revenue | 10.2% | 9.0% | 12.7% | 13.5% | 11.6% | 10.9% | 8.9% | 9.5% | 5.6% | 6.9% | | 11.9% |
| | | | | | | | | | | | |
Interest Expense | 3 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 1 | 5 | | 6 |
Pre-tax Income | 101 | 89 | 113 | 100 | 85 | 84 | 66 | 83 | 74 | 121 | | 188 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | (3) | 1 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (39) | (34) | (40) | (36) | (29) | (31) | (30) | (24) | (18) | (29) | | (52) |
Net Income to Company | 62 | 55 | 73 | 65 | 54 | 54 | 36 | 60 | 55 | 92 | | 136 |
% Margin | 6.5% | 5.7% | 8.3% | 8.8% | 7.3% | 7.0% | 4.8% | 6.8% | 4.3% | 5.5% | | 8.9% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | 0 | 0 | 0 | (1) | (1) | (0) | (1) | (0) | 2 | | 5 |
Net Income to Stockholders | 62 | 55 | 73 | 65 | 53 | 53 | 35 | 59 | 55 | 93 | | 141 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 3 | (1) | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 62 | 55 | 73 | 65 | 56 | 53 | 35 | 59 | 55 | 93 | | 141 |
% Margin | 6.5% | 5.7% | 8.4% | 8.9% | 7.6% | 6.8% | 4.8% | 6.8% | 4.3% | 5.6% | | 9.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 8.65 | 7.70 | 10.21 | 9.02 | 7.74 | 7.32 | 4.95 | 8.21 | 7.66 | 13.02 | | 19.63 |
Diluted EPS (Continuing Ops) | 8.65 | 7.70 | 10.21 | 9.02 | 7.74 | 7.32 | 4.95 | 8.21 | 7.66 | 13.02 | | 19.63 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | | 7.18 |
WA Diluted Shares Out. | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | | 7.18 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 101 | 89 | 113 | 100 | 85 | 84 | 66 | 83 | 74 | 121 | | 188 |
Addback: Net Interest Expense | (3) | (2) | (2) | (2) | (1) | (0) | (0) | (0) | (1) | (5) | | (6) |
Addback: Other Non Operating Expenses, Total | 0 | (0) | (1) | (0) | (1) | (2) | (2) | (2) | (3) | (5) | | (8) |
Addback: Depreciation & Amortization | 45 | 48 | 49 | 42 | 53 | 54 | 56 | 59 | 58 | 47 | | 47 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | (5) | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (2) | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 0 | 5 | | 5 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | (1) | 0 | 0 | 0 | (0) | (7) | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 18 | 2 | (0) | 1 | 5 | | 5 |
Adjusted EBITDA | 141 | 134 | 161 | 142 | 137 | 147 | 151 | 139 | 129 | 168 | | 232 |
% Margin | 14.7% | 13.9% | 18.4% | 19.4% | 18.7% | 19.1% | 20.4% | 16.0% | 9.9% | 10.0% | | 15.2% |
| | | | | | | | | | | | |
Adjusted EBIT | 96 | 86 | 112 | 100 | 84 | 93 | 95 | 81 | 70 | 120 | | 185 |
% Margin | 9.9% | 8.9% | 12.8% | 13.6% | 11.4% | 12.1% | 12.9% | 9.3% | 5.4% | 7.2% | | 12.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 62 | 55 | 73 | 65 | 54 | 54 | 36 | 60 | 55 | 92 | | 136 |
Addback: Unusual Items | (3) | (0) | 2 | 1 | 1 | 11 | 32 | (0) | 1 | 10 | | 11 |
Less: Tax Benefit of Unusual Items (26%) | 1 | 0 | (0) | (0) | (0) | (3) | (8) | 0 | (0) | (3) | | (3) |
Adjusted Net Income | 60 | 55 | 74 | 66 | 54 | 62 | 59 | 60 | 56 | 99 | | 144 |
% Margin | 6.2% | 5.7% | 8.4% | 9.0% | 7.4% | 8.1% | 8.0% | 6.8% | 4.4% | 5.9% | | 9.4% |